Proteomics

Dataset Information

0

Proteomic analysis of pleomorphic dermal sarcoma


ABSTRACT: In this study, we aimed to unravel the molecular underpinnings of pleomorphic dermal sarcomas (PDS), rare skin tumors often seen in sun-exposed regions. Using mass spectrometry, we examined proteomic profiles of 20 samples of normal healthy skin tissue (SNT), 27 malignant melanomas (MM), 20 cutaneous squamous cell carcinomas (cSCC), and 24 PDS. Our analysis aimed to: I.) Determine the potential cell of origin for PDS by correlating protein abundance to tumor purity using both RNA- and DNA-sequencing data. II.) Investigate receptor/ligand (R/L) interactions and their related pathways, highlighting distinct signaling differences between cSCC, MM, and PDS. III.) Identify differential protein markers, such as MAP1B_HUMAN, that can distinguish between cSCC, MM, and PDS. IV.) Explore proteins linked to immunosuppression in PDS, with a focus on those related to the negative regulation of interferon-gamma signaling. Together, this comprehensive proteomic exploration provides valuable insights into PDS and potential therapeutic targets.

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Melanoma Cell, Skin Cancer Cell

DISEASE(S): Skin Cancer

SUBMITTER: Prerana Wagle  

LAB HEAD: Sebastian Klein

PROVIDER: PXD046388 | Pride | 2024-06-16

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
2813_01.raw Raw
2813_02.raw Raw
2813_03.raw Raw
2813_04.raw Raw
2813_05.raw Raw
Items per page:
1 - 5 of 100
altmetric image

Publications

Proteomic analysis of pleomorphic dermal sarcoma reveals a fibroblastic cell of origin and distinct immune evasion mechanisms.

Klein Sebastian S   Tolkach Yuri Y   Reinhardt Hans Christian HC   Buettner Reinhard R   Quaas Alexander A   Helbig Doris D  

Scientific reports 20240531 1


Pleomorphic dermal sarcomas are infrequent neoplastic skin tumors, manifesting in regions of the skin exposed to ultraviolet radiation. Diagnosing the entity can be challenging and therapeutic options are limited. We analyzed 20 samples of normal healthy skin tissue (SNT), 27 malignant melanomas (MM), 20 cutaneous squamous cell carcinomas (cSCC), and 24 pleomorphic dermal sarcomas (PDS) using mass spectrometry. We explored a potential cell of origin in PDS and validated our findings using public  ...[more]

Similar Datasets

2022-11-15 | PXD031535 | Pride
2023-10-24 | PXD041004 | Pride
2024-07-29 | PXD049992 | Pride
2023-09-15 | PXD044514 | Pride
2023-09-15 | PXD044634 | Pride
2023-09-15 | PXD044653 | Pride
2023-09-15 | PXD044631 | Pride
2019-08-06 | PXD011209 | Pride
2022-08-30 | PXD018256 | Pride
2023-01-11 | PXD033024 | Pride